Newsfeed

Yale study provides a breath of hope for pulmonary hypertension patients
Most of us draw roughly 25,000 breaths a day without any thought. But for patients with pulmonary hypertension, a life-threatening increase in blood pressure in the lungs, even the smallest task can leave them gasping for air. A new study by researchers at Yale School of Medicine offers insight into the function of cells linked to this incurable and often fatal illness. Published Feb. 27 in Cell Reports, the study is the first to explore the c…
Harper Government building pan-Canadian networks to strengthen health research
February 24, 2014 – Ottawa, Ontario – Canadian Institutes of Health Research Federal Health Minister Rona Ambrose was joined by Dr. Alain Beaudet, President of the Canadian Institutes of Health Research, and Dr. Duncan Stewart, CEO and Scientific Director of the Ottawa Hospital Research Institute, to announce the launch of three pan-Canadian research networks: the Canadian Respiratory Research Network, the Canadian Stroke Prevention Interventi…
New hope: Researchers discover genetic mutations that cause rare and deadly lung disease
SALT LAKE CITY – A team of researchers, led by physicians and scientists at Intermountain Healthcare's Intermountain Medical Center and ARUP Laboratories, has made a medical breakthrough by discovering genetic mutations that cause a rare and deadly lung disease. The disease, pulmonary capillary hemangiomatosis or PCH, is a rare cause of pulmonary hypertension, which occurs predominantly in young adults. PCH affects less than one in a million p…
Caripul now available under exceptional access program
CARIPUL® (room temperature stable epoprostenol) Is Now Available Under Exceptional Access Program for Patients with Ontario Drug Benefit Coverage. CARIPUL®, a recently-introduced room temperature stable formulation of epoprostenol for continuous IV infusion in patients with NYHA functional class III or IV pulmonary hypertension, is now being reimbursed under the Exceptional Access Program of Ontario’s Ministry of Health and Long-term Care. This…
Anti-Depressants Linked With Infant Pulmonary Hypertension
Pulmonary hypertension in infants may be linked to anti-depressant use on the part of mothers, according to a new study from the Sunnybrook Health Sciences Centre in Ontario, Canada. The researcher team reviewed seven previous studies examining any links between selective serotonin reuptake inhibitor (SSRI) use and persistent pulmonary hypertension of the newborn PPHN). The researchers found that although only about 1 in 1,000 children deve…
Another piece of the PH puzzle gets plugged into place
Pulmonary hypertension, a dangerous increase in the pressure of blood vessels in the lung, is one nasty disease, as I wrote in a Stanford Medicine article a few years ago. As many as three times as many women – many of them quite young – as men are diagnosed with the spontaneous form of PH (which can also arise from scleroderma or bad pharmaceuticals). While an increasing number of pharmaceutical treatments and advocacy groups have made the diagn…
Women In Government Launches a Pulmonary Hypertension Legislative Toolkit
WASHINGTON, Jan. 3, 2014 /PRNewswire-iReach/ -- Women In Government (WIG) today announced the launch of its Pulmonary Hypertension Legislative Toolkit, designed to provide information and resources regarding Pulmonary Hypertension (PH) for women state legislators. (Photo: http://photos.prnewswire.com/prnh/20140103/MN39312) Each year, 10 to 15 million people are diagnosed with pulmonary hypertension, 200,000 are hospitalized, and more th…
New mitochondrial research offers hope to those suffering serious disease
(Medical Xpress)—Queen's University professor Stephen Archer's (Department of Medicine) research has revealed that in serious human diseases (such as pulmonary hypertension, lung cancer, cardiac arrest and neurologic disease) the cell's power source, known as mitochondria, displays an abnormal structure. Dr. Archer discussed his findings in a recent New England Journal of Medicine article. "This explosion in the understanding of the once secr…
To many, PH patients don't 'look' sick, but they are
You wouldn't guess that some pulmonary hypertension (PH) patients suffer from a life-threatening disease just by looking at them. However, everyday tasks, such as walking up a flight of stairs, can cause patients to pass out. Many living with this disease have to anticipate the next emergency room visit while running errands. Some regularly receive quizzical looks from unknowing strangers wondering why a healthy-looking person requires a handi…
Actelion receives Health Canada approval of Opsumit (macitentan)
(Thomson Reuters ONE via COMTEX) -- Actelion Pharmaceuticals Ltd / Actelion receives Health Canada approval of Opsumit (macitentan) for the long-term treatment of pulmonary arterial hypertension . Processed and transmitted by Thomson Reuters ONE. The issuer is solely responsible for the content of this announcement. ALLSCHWIL, SWITZERLAND - 12 NOVEMBER 2013 - Actelion Ltd (six:ATLN) announced today that Health Canada has granted a Notice of Co…
Recent News

Subscribe

Get the latest on PH treatments, community events and more when you subscribe to our newsletter

ImagineCan_Accreditation_Trustmark_ENGFR_WHT-FNL_white.png